https://www.clinicaltrialsarena.com/news/padcev-data-urothelial-cancer/
Padcev meets primary goal Seattle Genetics-Astellas' urothelial cancer trial
Sep 21, 2020 - Seattle Genetics and Astellas Pharma have reported that Padcev achieved its primary endpoint of overall survival in a Phase III trial in urothelial cancer.
seattle geneticsurothelial cancerpadcevmeetsprimary
https://astellascareers.jobs/military-bases/offutt-air-force-base/jobs/
Jobs - Astellas Pharmaceutical
jobsastellaspharmaceutical
https://newsroom.astellas.com/2026-04-24-astellas-amends-settlement-and-license-agreement-with-msn-regarding-myrbetriq
Astellas Amends Settlement and License Agreement with MSN regarding Myrbetriq®
Explore Astellas’ global press releases and discover the latest news and updates about Astellas.
license agreementastellasamendssettlementmsn
https://innovationsoftheworld.com/astellas-farma-portugal-we-live-the-astellas-way/
ASTELLAS FARMA PORTUGAL-WE LIVE THE ASTELLAS WAY - Innovations of the World
Astellas Farma Portugal is an affiliate of Astellas Pharma Inc., based in Tokyo, and globally one of the companies most focused on the investigation of
we livethe wayastellasfarmaportugal
https://www.companiesmarketcap.com/fr/astellas-pharma/actif-net/
Astellas Pharma (4503.T) - Actifs nets
Liste des principales entreprises publiques classées par actifs nets au bilan. Les actifs nets d'une entreprise sont la somme de ses actifs moins la somme de...
astellas pharmaactifsnets
https://caritassantiago.org/tag/astellas/
Astellas – Cáritas Arquidiocesana de Santiago
astellasarquidiocesanasantiago
https://capital.com/de-int/markets/shares/astellas-pharma-inc-aktienkurs
Astellas Pharma Inc. (4503) Aktie: Aktienkurs & Chart | Jetzt traden | Capital.com
Astellas Pharma Inc. (ticker: 4503) Echtzeit-Aktienwert, Investment, historische Daten, Rating und Finanzmarktinformationen bei Capital.com.
astellas pharmaincaktiechartjetzt
https://pj.jiho.jp/article/p-1226566727879
Astellas: Regnite Approved for RLS | PHARMA JAPAN
Astellas Pharma announced on January 18 that Regnite Tablets (gabapentin enacarbil) has received mar…
astellasapprovedrlspharmajapan
https://www.aveooncology.com/aveo-and-astellas-to-end-worldwide-collaboration-license-agreement-for-development-and-commercialization-of-tivozanib/
AVEO and Astellas to End Worldwide Collaboration & License Agreement for Development and...
Jun 30, 2023 - Download PDF Phase 2 Colorectal Cancer Study Discontinued AVEO to Outline Corporate Strategy During 2013 Financial Results Conference Call on March 13, 2014...
license agreementaveoastellasendworldwide
https://astellascareers.jobs/job-titles/womens-health-business-specialist-el-paso-tx/jobs/
Jobs - Astellas Pharmaceutical
jobsastellaspharmaceutical
Sponsored https://ctwmsg.com/?siteId=jasmin&cobrandId=&superCategoryName=&categoryName=mature&pageName=listpage&prm[psid]=robuta&prm[pstool]=211_16&prm[psprogram]=pps&prm[campaign_id]=&subAffId=
Live Sex Cams and Adult Chat with Webcam Girls | LiveJasmin
Chat for free on LiveJasmin and watch HD Live Sex cam shows! 2000+ Models are waiting for You, no registration required.
https://www.fiercebiotech.com/biotech/astellas-notches-another-protein-degrader-pact-21m-upfront-peptidream-partnership
Astellas pays PeptiDream $21M in latest protein degrader pact
Jul 25, 2023 - Astellas has followed up agreements with the likes of Cullgen and Generian by tapping PeptiDream for its latest degrader partnership.
astellaspayslatestproteindegrader
https://www.prnewswire.co.uk/news-releases/astellas-pharma-inc-announcement-of-regulatory-submission-for-mirabegron-ym178-a-treatment-for-overactive-bladder-in-us-and-europe-145096225.html
Astellas Pharma Inc.: Announcement of Regulatory Submission for Mirabegron (YM178), a Treatment for...
/PRNewswire/ -- Astellas Pharma Inc. (Tokyo:4503, "Astellas") today announced the submission of a New Drug Application and Market Authorisation Application...
astellas pharmaincannouncementregulatorysubmission
https://www.onemedplace.com/ironwood-receives-75m-from-astellas-for-ibs-drug/
Ironwood Receives $75M from Astellas for IBS Drug – OneMedPlace | Blog
ironwoodreceivesastellasibsdrug
https://www.pompecanada.com/blog/news/astellas-enters-into-definitive-agreement-to-acquire-audentes-therapeutics/
Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics - Canadian Association...
Dec 3, 2019 - This development should provide Audentes with additional resources for their gene therapy programs, including a Phase 1/2 study for Pompe disease.
enters intodefinitive agreementastellasacquireaudentes
https://www.chemdiv.com/company/media/pharma-news/2025/astellas-seeks-conditional-approval-for-ga-treatment-in-japan/
Astellas seeks conditional approval for GA treatment in Japan
Astellas seeks conditional approval for GA treatment in Japan
in japanastellasseeksconditionalapproval
https://raiox.pt/tag/astellas-farma/
Arquivo de Astellas Farma - RAIOX - O seu jornal de saúde diário
arquivoastellasfarmaseujornal
https://astellascareers.jobs/job-titles/mslsr-msl-womens-health-new-england-region/jobs/
Jobs - Astellas Pharmaceutical
jobsastellaspharmaceutical
https://www.planet-health.dk/sundt-underliv/inkontinens-begraenser-aeldres-livsudfoldelse/attachment/astellas-artikel-888x500/
Astellas artikel 888x500 - Planet Health
astellasartikelplanethealth
https://www.saludyfarmacos.org/lang/en/boletin-farmacos/boletines/ago201802/65_jo/
Johnson & Johnson tiene la mayor cantidad de dinero para adquirir biofarmacéuticas, Astellas es el...
la mayores eljohnsontienecantidad
https://www.diwou.com/2025/06/05/astellas-chooses-veeva-vault-crm-as-global-standard/
Astellas Chooses Veeva Vault CRM as Global Standard - American Biotech News
Jun 5, 2025 - Vault CRM will support Astellas’ commercial agility and execution SINGAPORE, June 5, 2025 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced Astellas...
standard americanastellaschoosesveevavault
https://extraetf.com/de/stock-profile/JP3942400007?tab=chart
Astellas Pharma Inc. Aktie | Kurs | Dividende | Nachrichten (856273, JP3942400007)
Astellas Pharma Inc. (ISIN: JP3942400007, WKN: 856273): ✓ Kurs der Astellas Pharma Inc. Aktie ✓ Dividenden-Rendite und Termine, ✓ aktuelle Nachrichten ✓...
astellas pharmaincaktiekursdividende
https://pharsight.greyb.com/company/astellas-drug-patent-portfolio
Astellas Drug Patent Portfolio
Explore the complete list of drugs in Astellas's Drug Patent Portfolio, along with the list of patents protecting each drug.
drug patentastellasportfolio
https://nibbp2p.org/2023/05/02/received-investigator-fees-from-chemocentryx-and-travel-support-from-otsuka-astellas-shire-koeln-fortune-and-dfg/
received investigator fees from ChemoCentryx and travel support from Otsuka, Astellas, Shire,...
travel supportinvestigatorfeeschemocentryxotsuka
https://www.cogentialit.com/edi/for-astellas-pharma/
Astellas Pharma EDI Requirements | Cogential IT
Launch Astellas Pharma EDI integration with 810 invoices and 844 chargeback claims, error checks, and supplier enablement.
astellas pharmaedirequirements
https://www.signalhire.com/companies/asuterasuzhiyao-zhu
Astellas Pharma Information | SignalHire Company Profile
The business currently specializes in Pharmaceuticals area. The company has 10000+ employees. Register with SignalHire to connect with Astellas Pharma...
astellas pharmacompany profileinformation
https://thriftymeds.com/shop/myrbetriq-mirabegron-astellas-pharma-canada-2/
Myrbetriq( Mirabegron) Extended release tablet . Cannot be split .Astellas Pharma Canada |...
Online pharmacy located in Canada, shipping to USA. Get your prescriptions for less.
extended releaseastellas pharmamyrbetriqmirabegrontablet
https://leadiq.com/c/astellas-pharma-us/5a1d9719230000540085b3c4
Astellas Pharma US Company Overview, Contact Details & Competitors | LeadIQ
Astellas Pharma US operates as the U.S. affiliate of Tokyo-based Astellas Pharma Inc. and serves as the Americas headquarters, located in Northbrook…
astellas pharma uscompany overviewcontact detailscompetitors
https://newsroom.astellas.com/china-news?l=50
China news | Astellas
Explore Astellas China’s press releases and discover the latest news and updates about Astellas.
china newsastellas
https://astellascareers.jobs/san-francisco-ca/womens-health-region-business-lead-northern-california-salt-lake-city/B3E5215CA79848F99AB7FFD76AC5DD0F/job/
Jobs - Astellas Pharmaceutical
jobsastellaspharmaceutical
https://www.biospace.com/astellas-inks-potential-800m-deal-with-kelonia-for-in-vivo-gene-delivery-tech
Astellas Inks Potential $800M Deal with Kelonia for In Vivo Gene Delivery Tech - BioSpace
Feb 16, 2024 - Kelonia Therapeutics’ in vivo gene placement system is being tapped to help Astellas Pharma expand its portfolio of in vivo CAR-T cell therapies for cancer.
deal within vivogene deliveryastellasinks
https://www.fomf.ch/fr-CH/partnerforum/Astellas/Gyn%C3%A4kologie
Astellas Pharma AG dans le forum de formation continue des partenaires.
Découvrez des vidéos passionnantes et d'autres informations sur les derniers développements médicaux de Astellas Pharma AG dans le forum de formation continue...
astellas pharmaformation continuedansforumdes
https://astellascareers.jobs/locations/arlington-va/jobs/
Jobs - Astellas Pharmaceutical
jobsastellaspharmaceutical
https://www.kos.ie/calendar/astellas-in-office-assessments-no-booking-link-81
Astellas In-Office Assessments (No-Booking Link) | KOS.ie
in officebooking linkastellasassessmentskos
https://nhathuoc84.com/san-pham/xtandi-40mg-astellas/
Xtandi 40mg Astellas điều trị ung thư tuyến tiền liệt
Xtandi 40mg Astellas với thành phần chính là Enzalutamide được chỉ định để điều trị ung thư tuyến tiền liệt, có chỉ định từ bác sĩ
xtandiastellasung